Key result
Remote monitoring of cardiac implantable electronic devices significantly reduced the overall mean annual cost per patient compared with standard care (€482.87 vs €1044.89; P < .0001).
Why the study?
Does remote monitoring reduce healthcare and patient costs compared to standard care in patients with cardiac implantable electronic devices?
Observational (n=209)
Does remote monitoring reduce healthcare and patient costs compared to standard care in patients with cardiac implantable electronic devices?
Absolute Event Rate: 482.87% vs 1044.89%
p-value: p=<.0001
Remote monitoring of CIEDs is cost-saving for both the healthcare system and patients, primarily driven by a reduction in cardiovascular hospitalizations and in-hospital follow-up visits.
No takes yet. Share an insight, caveat, or question.
Associated with lower CIED costs in observational data; leaves open confirmation in randomized trials before practice change.
Ricci et al. (2016) conducted an observational in Cardiac implantable electronic devices (CIEDs) (n=209). Remote monitoring vs. Standard care was evaluated on Overall mean annual cost per patient from the health care system perspective (p=<.0001). Remote monitoring of cardiac implantable electronic devices significantly reduced the overall mean annual cost per patient compared with standard care (€482.87 vs €1044.89; P < .0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: